Challenges Faced by Biotech Companies in Hitting Milestones

Many biotech companies trade below cash due to the way they hit milestones and receive funding./nTech companies often have multiple milestones they need to hit before becoming profitable./nSACs may have to hit certain milestones to become profitable, which may require multiple rounds of funding.

Play episode from 01:16:17

chevron_right

Transcript

chevron_right